(Q45264304)

English

Concomitant dosing of famotidine with a triple therapy increases the cure rates of Helicobacter pylori infections in patients with the homozygous extensive metabolizer genotype of CYP2C19.

scientific article published in February 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Concomitant dosing of famotidine with a triple therapy increases the cure rates of Helicobacter pylori infections in patients with the homozygous extensive metabolizer genotype of CYP2C19. (English)

1 reference

Europe PubMed Central

11 December 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

K Okudaira

1

1 reference

Europe PubMed Central

11 December 2017

T Furuta

2

1 reference

Europe PubMed Central

11 December 2017

N Shirai

3

1 reference

Europe PubMed Central

11 December 2017

M Sugimoto

4

1 reference

Europe PubMed Central

11 December 2017

S Miura

5

1 reference

Europe PubMed Central

11 December 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

11 December 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

11 December 2017

21

1 reference

Europe PubMed Central

11 December 2017

4

1 reference

Europe PubMed Central

11 December 2017

491-497

1 reference

Europe PubMed Central

11 December 2017

Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Cure of refractory duodenal ulcer and infection caused by Helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Omeprazole versus ranitidine: short-term triple-therapy in patients with Helicobacter pylori-positive duodenal ulcers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02353.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2005.02353.X

1 reference

Europe PubMed Central

11 December 2017

1 reference

Europe PubMed Central

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45264304&oldid=2042104619"